Patients are living with advanced cancer for ever more prolonged periods of time. But information and support services have been slow to catch up with clinical progress, and the needs of this rapidly growing group [more]
Pat Price pioneered the use of PET imaging to investigate how cancer drugs move in the body and the effect they have. She worries that oncology has lost its way: translational research’ has become a [more]
Non-small-cell lung cancers (NSCLC) covers a heterogeneous group of diseases, accounting for around 80% of all lung cancers, which were previously lumped together because there was no apparent reason to use different therapeutic approaches for [more]
Faced with escalating drug prices and rising patient expectations, Europe’s governments are anxious to ensure value for money from their overstretched health budgets. But how can one measure the value of a few extra precious [more]
Polish surgeon Marek Nowacki has always had a very dynamic approach to cancer care, travelling extensively to pick up new tricks and techniques, and publishing his own innovations to spread the benefit. Today, thanks to [more]
Cetuximab increases overall survival in patients with recurrent or metastatic squamous cell carcinomas of the head and neck. Reasonable treatment strategies include the use of first-line platinum, 5-fluorouracil and cetuximab combination, or cetuximab used following [more]
The optimal timing for rectal cancer surgery after neoadjuvant chemoradiotherapy, in terms of risk of complications or tumour response, remains uncertain. Download full article
Selected repor ts edited by Janet Fricker Download full article
More than 20 years since the WHO published its three-step guideline for controlling cancer pain, European patients are still complaining of pain that is long lasting, interferes with their daily activities and can even be [more]
Chemobrain’ is an informal term coined by patients who are or were on chemotherapy, to express the feeling of being not quite switched on or able to think clearly and focus on the [more]
Images of gaunt, wasted bodies are shocking and often linked to feelings of shame, blame or guilt. When patients with advanced cancer begin to look this way, the problem lies with the cancer more than [more]
The genomic era offers enormous potential for patients with rare cancers, but progress is being held back by structures that separate research from care, regulatory practices that penalise small patient populations, and rules that restrict [more]